B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 29.05 SEK -1.19% Market Closed
Market Cap: 1.9B SEK

Intrinsic Value

The intrinsic value of one BINV stock under the Base Case scenario is 83.48 SEK. Compared to the current market price of 29.05 SEK, BioInvent International AB is Undervalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BINV Intrinsic Value
83.48 SEK
Undervaluation 65%
Intrinsic Value
Price
B
Base Case Scenario

Valuation History
BioInvent International AB

BINV
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BINV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

BioInvent International AB
STO:BINV
SE
Biotechnology
Market Cap
1.9B SEK
IPO
Jun 12, 2001
SE
Biotechnology
Market Cap
1.9B SEK
IPO
Jun 12, 2001
Price
krfalse
EPS
krfalse
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BINV?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about BioInvent International AB
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioInvent International AB

Current Assets 943.2m
Cash & Short-Term Investments 867.2m
Receivables 65.1m
Other Current Assets 11m
Non-Current Assets 46m
PP&E 17.7m
Other Non-Current Assets 28.3m
Efficiency

Free Cash Flow Analysis
BioInvent International AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioInvent International AB

Revenue
44.7m SEK
Operating Expenses
-515.7m SEK
Operating Income
-471.1m SEK
Other Expenses
41.7m SEK
Net Income
-429.4m SEK
Fundamental Scores

BINV Profitability Score
Profitability Due Diligence

BioInvent International AB's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
Declining ROE
Negative 1-Year Revenue Growth
21/100
Profitability
Score

BioInvent International AB's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

BINV Solvency Score
Solvency Due Diligence

BioInvent International AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

BioInvent International AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BINV Price Targets Summary
BioInvent International AB

Wall Street analysts forecast BINV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BINV is 81.6 SEK with a low forecast of 80.8 SEK and a high forecast of 84 SEK.

Lowest
Price Target
80.8 SEK
178% Upside
Average
Price Target
81.6 SEK
181% Upside
Highest
Price Target
84 SEK
189% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

BioInvent International AB
does not pay dividends
Shareholder Yield

Current shareholder yield for BINV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BINV Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BINV stock?

The intrinsic value of one BINV stock under the Base Case scenario is 83.48 SEK.

Is BINV stock undervalued or overvalued?

Compared to the current market price of 29.05 SEK, BioInvent International AB is Undervalued by 65%.

Back to Top